Huntingtin suppression restores cognitive function in a mouse model of Huntington’s diseaseAmber L. Southwell, Michael R. Hayden, Holly Kordasiewicz et al.|Science Translational Medicine|2018Cited by 123
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyRalf Reilmann, Hope Heller, Andrew McGarry et al.|The Lancet Neurology|2018Cited by 108
Abnormal brain development in child and adolescent carriers of mutant huntingtinEllen van der Plas, Peg Nopoulos, Douglas R. Langbehn et al.|Neurology|2019Cited by 96
Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington’s disease decades before clinical motor diagnosisRachael I. Scahill, Sarah J. Tabrizi, Mena Farag et al.|Nature Medicine|2025Cited by 53
Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in ChildrenLauren M. Byrne, Edward J. Wild, Douglas R. Langbehn et al.|Movement Disorders|2022Cited by 22